Long-term clinical impact of angiographic complexity in left main trifurcation percutaneous coronary interventions
Mila Kovacevic1,2,3,4, Francesco Burzotta5,2, Goran Stankovic6,7
1Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
Insights
Percutaneous coronary intervention (PCI) for unprotected left main trifurcation (LMT) shows good success rates. Lesion complexity, measured by a modified Medina score, predicts long-term outcomes in these patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Limited data exists on long-term outcomes for unprotected left main trifurcation (LMT) treated with percutaneous coronary intervention (PCI).
- Previous studies were small, necessitating larger investigations to identify outcome determinants.
Purpose of the Study:
- To evaluate clinical, anatomical, and procedural factors influencing long-term outcomes in patients with unprotected LMT undergoing PCI.
- To assess the efficacy and safety of PCI in this complex patient group.
Main Methods:
- A multicenter retrospective study analyzed 103 patients with unprotected LMT treated with drug-eluting stents.
- Lesion complexity was assessed using a modified Medina LMT score.
- Major adverse cardiovascular events (MACE) were tracked over 3 years.
Main Results:
- Procedural success was high (96.1%), with 17.9% experiencing MACE over 3 years, primarily target lesion revascularization (11.9%).
- The modified Medina LMT score was the sole independent predictor of MACE (HR 1.538).
Conclusions:
- PCI offers a high procedural success rate and acceptable long-term outcomes for unprotected LMT lesions.
- Baseline LMT lesion complexity, evaluated by the modified Medina LMT score, is a critical factor influencing long-term clinical outcomes.
Background:
Current evidence on the long-term outcome and its determinants in patients with unprotected left main trifurcation (LMT) treated with percutaneous coronary intervention (PCI) is based on small-sized studies. We aimed to assess the clinical, anatomical and procedural factors impacting long-term clinical outcomes of patients with LMT treated by PCI.
Methods:
We conducted a multicenter retrospective study on consecutive patients with unprotected LMT in stable or acute coronary settings who underwent PCI with drug-eluting-stent implantation. Primary endpoint was major adverse cardiovascular events (MACE), defined as composite of all-cause death, myocardial infarction, and target lesion revascularization. LMT lesions complexity was graded according to a modified Medina LMT score, which, together with standard criteria of >50% stenosis in any of the branches, included the presence of disease extent >5 mm in the two major side-branches.
Results:
A total of 103 patients were analyzed, mean age 67.5 years, 37.9% with diabetes mellitus, 47.6% presenting with acute coronary syndrome, 8.7% in cardiogenic shock, with a mean SYNTAX Score of 28.1. Procedural success (angiographic success without in-hospital MACE) was achieved in 99 patients (96.1%). During 3-year follow-up, 18 patients (17.9%) experienced MACE, mainly due to target lesion revascularization (TLR), which occurred in 12 patients (11.9%). At multivariable analysis, modified Medina LMT score was the only independent predictor of MACE (HR 1.538 [1.081-2.189], P=0.017).
Conclusions:
PCI in patients with LMT is associated with a high procedural success rate and acceptable long-term clinical outcomes. Baseline LMT lesion complexity, assessed by an original modified Medina LMT score, is an independent driver of long-term clinical outcomes.
More Related Videos
08:12Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Peripheral Artery Disease III: Interprofessional Care
